BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
VCs Invest $23M In Roche Holding Spinout Afferent Pharmaceuticals
News | 12. 16. 2009
Afferent Pharmaceuticals
Venture firms are investing $23 million to spin out a start-up from Roche Holding Ltd. that plans to attack chronic pain in a new way.
